Literature DB >> 24316310

Endometrial cancer in Asian and American Indian/Alaskan Native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women.

Haider Mahdi1, Cary Jo Schlick2, Li-Lian Kowk3, Mehdi Moslemi-Kebria2, Chad Michener2.   

Abstract

OBJECTIVE: The objective of this study is to compare survival of Asian (AS), American Indian/Alaskan Native (AI/AN) and non-Hispanic white (NHW) women with endometrial adenocarcinoma (EC).
METHODS: Patients with EC were identified from the Surveillance, Epidemiology, and End Results program from 1988 to 2009. Kaplan-Meier survival methods and Cox proportional hazards regression were performed.
RESULTS: Of the 105,083 women, 97,763 (93%) were NHW, 6699 (6.4%) were AS and 621 (0.6%) were AI/AN. AS and AI/AN were younger than NHW with mean age of 57.7 and 56.5 vs. 64.3 years (p < 0.001 and 0.059). Advanced stage and high-risk histology were more prominent in AS than NHW (15.6% vs. 13.3%, p = 0.04, 10.6% vs. 9.6%, p= 0.041). Lymphadenectomy was performed more frequently in AS than NHW (56.7% vs. 48.2%, p < 0.001). Asian immigrants were younger than Asian natives (mean age 57 vs. 60.5 years, p < 0.001). In multivariate analysis, AS had better overall (OS) (HR 0.86, 95% CI 0.81-0.91, p < 0.001) and cancer-specific survival (CSS) (HR 0.92, 95% CI 0.84-1.00, p = 0.05) than NHW. Further, Asian immigrants had better OS (HR 0.83, 95% CI 0.73-0.94, p = 0.002) and CSS (HR 0.66, 95% CI 0.54-0.80, p < 0.001) than Asian natives. In contrast, AI/AN had worse OS (HR 1.35, 95% CI 1.15-1.59, p < 0.001) but no difference in CSS (HR 1.06, 95% CI 0.80-1.40, p = 0.69) than NHW.
CONCLUSIONS: Asians were younger at presentation, more likely to have lymphadenectomy and had an improved outcome compared to NHW. Interestingly, Asian immigrants had more favorable outcome than Asians born in the US. Further studies are warranted to find possible explanations for such a difference.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asian, American Indian/Alaskan Native, endometrial cancer; Cancer-specific survival; Overall survival; Racial disparity

Mesh:

Year:  2013        PMID: 24316310     DOI: 10.1016/j.ygyno.2013.11.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.

Authors:  XueLian Li; SaiHua Zheng; ShangJie Chen; Feng Qin; Sandy Lau; Qi Chen
Journal:  Tumour Biol       Date:  2015-02-04

2.  Lack of improvement in survival rates for women under 50 with endometrial cancer, 2000-2011.

Authors:  Ana M Rodriguez; Kathleen M Schmeler; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-15       Impact factor: 4.553

3.  Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer.

Authors:  Qi Chen; Mancy Tong; Fang Guo; Sandy Lau; Min Zhao
Journal:  J Cancer       Date:  2015-09-03       Impact factor: 4.207

4.  Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause.

Authors:  Yifei Gao; Xujing Dai; Limei Chen; Arier C Lee; Mancy Tong; Michelle Wise; Qi Chen
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

5.  Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database.

Authors:  Min-Qiang Lin; Yue-Ping Li; San-Gang Wu; Jia-Yuan Sun; Huan-Xin Lin; Shi-Yang Zhang; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2016-10-19       Impact factor: 4.147

6.  The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer.

Authors:  Jiayi Wan; Yongxiang Yin; Min Zhao; Fang Shen; Miaoxin Chen; Qi Chen
Journal:  Oncotarget       Date:  2017-06-17

7.  Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?

Authors:  Fang Shen; Yifei Gao; Jingxin Ding; Qi Chen
Journal:  Oncotarget       Date:  2017-01-03

8.  Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study.

Authors:  Hung Chun Fu; Jen Ruei Chen; Min Yu Chen; Keng Fu Hsu; Wen Fang Cheng; An Jen Chiang; Yu Min Ke; Yu Chieh Chen; Yin Yi Chang; Chia Yen Huang; Chieh Yi Kang; Yuan Yee Kan; Sheng Mou Hsiao; Ming Shyen Yen
Journal:  J Gynecol Oncol       Date:  2018-05-15       Impact factor: 4.401

9.  Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

Authors:  Ana M Rodriguez; Efstathia Polychronopoulou; Enshuo Hsu; Rahul Shah; Kelly Lamiman; Yong-Fang Kuo
Journal:  Gynecol Oncol       Date:  2020-11-19       Impact factor: 5.482

10.  The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.

Authors:  Fang Shen; Shouzhen Chen; Yifei Gao; Xujing Dai; Qi Chen
Journal:  Oncotarget       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.